CommunityFood & Appetite

Appetite suppression alone or extra metabolic actions like GLP-1 drugs?

4 replies4 peopleJul 3, 2026☆ Follow
Summary

Does this amylin agonist drive weight loss only by curbing hunger or through other metabolic changes similar to GLP-1 agonists?

Public information indicates appetite reduction is the main mechanism so far, with no clear published data showing independent boosts to energy expenditure or broad metabolic shifts. Some discussion raises the possibility of interactions with leptin pathways that could affect long-term body weight regulation beyond immediate hunger, though this remains speculative and based mainly on animal work. Participants note the heart-rate effects are intriguing but do not necessarily imply higher metabolism.

What this discussion establishesWhere people disagree

Whether amylin agonists provide benefits beyond what GLP-1 drugs already achieve through appetite control

Still open

Exact mechanism of action and any non-appetite effects in humans

Nothing here is advice.

4 replies · 4 people
CopperAlder30archiveopening postJul 3

From what I've seen, this compound seems to reduce hunger more than the main three options currently available. I'm trying to find clear details on whether that's the only way it leads to weight loss or if it also changes metabolism in other ways the way GLP-1 drugs do. As a user of one of those who's only averaging half a pound a week because side effects limit my dose, the reported drop in heart rate sounds useful since my current medication raises it and interferes with sleep and exercise. Extra hunger control isn't something I need, so I'm mainly interested in the mechanism. Has anyone come across literature on this?

GreyHarbour68archiveJul 3
↳ replying to @CopperAlder30 (opening post)

From everything that's publicly available so far, reducing appetite looks like the main driver of the weight loss. I haven't found any published evidence that it raises energy expenditure on its own or produces the wider metabolic changes seen with GLP-1 agonists. The drops in heart rate and blood pressure are noteworthy, but they don't necessarily mean higher metabolism and could even suggest the opposite.

CopperAlder30archiveJul 3
↳ replying to @GreyHarbour68

I had the same reaction; it feels counterintuitive. It will be interesting to see how the data develop, especially with the strong trial results that are coming out.

WarmMeadow92archiveJul 11

This idea has been on my mind as well. Should these substances only act through curbing hunger, my interest in this new option wouldn't make much sense, since other medications already handle that aspect effectively. From the details I've come across, these substances seem capable of additional actions. They connect with leptin mechanisms in the brain and, according to research on animals, can somewhat bring back sensitivity to leptin. Individuals carrying extra weight typically show elevated levels of leptin produced by adipose tissue. Yet the brain often shows reduced reaction to the message leptin sends about stored energy over time. Theoretically, this could affect how the body maintains or protects its weight level beyond mere feelings of hunger. One might draw a loose link to ideas about a preferred weight range, even if those ideas are still contested. It's much too soon to claim this compound alters anyone's preferred weight range or that its impact on reducing weight in people stems mainly from better leptin response. Still, that potential explains my fascination with these substances.

AmberCompass48archiveJul 11

I haven't heard that this one is stronger than the main three. Can you share a reference for that?

Related discussions

Add your experience

If you have tried it, this topic is still open. Sign in to reply — it takes a minute.